To all concernedFebruary 1, 2017
Company:FINDEX Inc.
Representive:President & CEO
Teruo Aibara(Securities code:3649)
Contact:Director and Head of Administration
Atsushi Fujita(TEL:+81-89-947-3388 )Notice on Establishment of Consolidated Subsidiary
FINDEX Inc. (the "Company") hereby announces that its Board of Directors has resolved at the meeting held today that theCompany will establish a new consolidated subsidiary as follows:
1.

Purpose of establishment
The Company has resolved to establish a subsidiary by investing a 53.8% stake as follows in order to further expand andenhance its business.
The subsidiary will be established jointly with Eagle Matrix Co., Ltd. ("Eagle Matrix"), which has strengths in businessstrategy and consulting operations in the data science field, and will be a consulting company specializing in medical strategy,
medical data analysis utilizing AI technology and operations related to data health.
Eagle Matrix has a variety of overseas experiences such as engaging in the establishment of new health care service utilizing
medical ICT in collaboration with universities, medical institutions and enterprises in Manchester in Britain. Eagle Matrix also
widely contributes in relevant fields in Japan by analyzing medical data in collaboration with local governments or byvisualizing the health trend of residents in communities and analyzing causal relationships utilizing various statistical methods
and thereby developing effective medical and welfare policies or interventions.
Eagle Matrix's staff who participate in the subsidiary have an abundance of experience and networks with overseas
government agencies and academic institutions, and are skilled at strategy design for the management, etc. of enterprises andpublic organizations inside and outside Japan, medical ICT system design and project management.
The subsidiary's business can construct a strong reciprocal relationship with the Company's medical system consultants, largescale medical institution networks and medical treatment data management solutions, etc. and will exert the maximum
synergy on both companies, contributing to the expansion of each party's business.

2.

Overview of the consolidated subsidiary to be established

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)

(10)

Name
L o c a t i o n
Tit l e an d na m e ofrepresentative
Details of businessC a p i t a l
Date of foundation
N e t
a s s e t s
G r o s s a s s e t s

Eagle Matrix Consulting Co., Ltd.
Hamamatsu-cho, Minato-ku, Tokyo
President & CEO: Yoshito Date

Medical consulting, medical system consulting
5 million yen
February 14, 2017
9 million yen
9 million yen
The Company 53.8%
Major shareholders andEagle Matrix Co., Ltd. 43.6%
their share-holding ratio
Officers and employees of Eagle Matrix Consulting Co., Ltd. 2.6%
C a p i t a l
The Company invests a 53.8% stake in the subsidiary.
relationshipP e r s o n n e l The Company's representative director will concurrently serve as anr e l a t i o n s h i p outside director.
Relationship between a
Tr a nsa c t i onlisted company and theNot applicable
relationshiprelevant company
Whether or nott h e r e l e v a n t The relevant company is a consolidated subsidiary of the Company
c o m p a n y i s a and therefore is a related party.
related party
1

(11)

Other

3. Overview of the joint investor(1)Name(2)
L o c a t i o n
Tit l e an d na m e of(3)
representative(4)
Details of business(5)
C a p i t a l(6)Date of foundation(7)
N e ta s s e t s(8)G r o s s a s s e t s
Major shareholders and(9)their share-holding ratio(10)

The Company has resolved at the Board of Directors' meeting held today that theCompany will provide the subsidiary with funds up to a total of 100 million yen as
needed by subscribing for bonds.

Eagle Matrix Co., Ltd.
Chiyoda-ku, Tokyo
President & CEO: Yoshito Date
Consulting, system consulting
25 million yen
July 14, 2000
Description is omitted because the information is not disclosed.
Description is omitted because the information is not disclosed.
Description is omitted because the information is not disclosed.

C a p i t a lrelationship
Personnel
relationship
Relationship between a
Tr a nsa c t i onlisted company and therelationshiprelevant company
Whether or not
the relevant
company is arelated party

Not applicableNot applicableNot applicableNot applicable

4. Schedule(1)
Date of resolution of theFebruary 1, 2017
Board of Directors(2)
Scheduled date ofFebruary 14, 2017
f o u n d a t i o n(3)Scheduled date of thec o m m e n c e m e n t o f February 14, 2017b u s i n e s s
5. Future outlook
The impact on business performance is currently being examined. Notifications of any matters that should be disclosed will bepromptly issued.

2